Neogen Corporation· NEOG

🇺🇸 US · MidSP600NASDAQ

Healthcare Medical - Devices Website

Price: $13.00
Day: +1.32%
Mkt Cap: $2.83B
52W Range: $5.10 – $13.07
Volume: 7.44M
Beta: 1.76

5D Framework

Company Overview

Snapshot of fundamentals, performance, and 5D scores.

5D scores: Quality 1.8, Peers 2.5, Valuation 1.0, Analysts 3.1, Holdings 3.4 (out of 5)
Market: $13.00 a share, market cap $2.83B, +129.3% over 12 months
Company: Healthcare · Medical - Devices, 2,636 employees, NASDAQ

Blog

Company Profile

Business fundamentals and company information

Business Description

Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.

Key Details

CEO

Mikhael Nassif

Employees

2,636

Headquarters

Lansing, MI, US

IPO Date

Aug 1989

Exchange

NASDAQ Global Select

Phone

517 372 9200

Healthcare · Medical - Devices

SEC filings

10-KJul 30, 2026 10-QApr 9, 2026 8-KAug 7, 2026

Price Performance

Recent price action and historical returns

Price Performance

$13.00

Historical Returns

Price performance over time

1 Day

+1.33%

5 Day

+10.36%

1 Month

+7.00%

3 Months

+39.63%

6 Months

+55.50%

YTD

+85.98%

1 Year

+129.28%

3 Years

-35.96%

5 Years

-68.58%

10 Years

-40.67%

Revenue Analysis

How the business makes money, by product and geography

2026 revenue · 2 products

Revenue to Profit Flow · 2026

How revenue flows through the P&L: Products → Total Revenue → COGS → Gross Profit → operating costs (R&D, SG&A). Operating costs ran past gross profit this year, so the shortfall enters as its own band and the rest of the P&L is listed under the chart.

Learn how to read flow diagrams

Below the line. Nothing flows through an operating loss, so these are shown as figures rather than as flows.

Operating Loss-$21.60M
Other income$70.20M
Interest-$57.60M
Tax$1.10M
Net Loss-$7.90M

5D Framework

Five lenses on the stock. Click any card to dive deeper.

Quality

Business fundamentals

1.8/5

Weak

View Details

Peers

Competitive position

2.5/5

Weak

View Details

Valuation

Model-based valuation (vs. price)

1.0/5

Well above estimate

View Details

Analysts

Wall Street sentiment

3.1/5

Neutral

View Details

Holdings

Smart money flows

3.4/5

Neutral

View Details

How to read these dimensions

The five dimensions are independent lenses on a company, not a single combined score. Read them together rather than in isolation: where one dimension scores differently from the others is often the most useful place to focus your own research. Each score is built from rules and weights you can adjust, so treat them as a transparent starting point for your analysis, not a recommendation to buy or sell.